BioSpace News Archive

Concept Medical Inc. (CMI) has been granted “Breakthrough Device Designation” from the U.S. Food and Drug Administration (FDA) for MagicTouch PTA (Percutaneous Transluminal Angioplasty), its Sirolimus drug coated balloon (DCB) catheter, for the treatment of Peripheral Artery Disease (PAD) in Below-the-Knee (BTK).

Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced financial results for the quarter ended June 30, 2019.

The Alzheimer’s Foundation of America (AFA) today announced a $100,000 grant to NYU Winthrop Hospital for a research project aimed at uncovering the underlying causes of Alzheimer’s disease and developing new treatments.

First-of-its-kind merger enabling greater access to coordinated primary, specialty and urgent care

New sub-licensing agreement allows LEO Pharma to help more people around the world with an additional treatment option for psoriasis

Insightful Science is a technology company with category-leading software designed to empower scientists at every step of the research and development process

IXORA-R is the first Phase 4 head-to-head study comparing efficacy between an IL-17A inhibitor and an IL-23/p19 inhibitor using PASI 100 as the primary endpoint

The July edition highlights the significant reduction in central-line associated bloodstream infection rates using ClearGuard HD caps vs. other commonly used caps.

The company is expanding its footprint in ten markets: Arizona, Florida, Georgia, Kansas, North Carolina, Ohio, South Carolina, Tennessee, Texas, and Washington.

Preparing to file first IND in September 2019